Pharma Reviews
Pages
(Move to ...)
Home
Pharma News
US FDA News
Pharma Jobs
▼
Wednesday, January 10, 2018
US FDA News: Clopidogrel Tablets USP, 75 mg by International Laboratories: Recall - Product Mislabeling
Missed doses of Clopidogrel increases the risk of heart attack and stroke which can be life threatening.
Read more:
Clopidogrel Tablets USP, 75 mg by International Laboratories: Recall - Product Mislabeling
‹
›
Home
View web version